Heartsciences provides business update and reports fiscal 2025 financial results

Southlake, tx, july 24, 2025 (globe newswire) -- heartsciences inc. (nasdaq: hscs; hscsw) ("heartsciences" or the "company"), an artificial intelligence (“ai”)-powered medical technology company transforming ecgs/ekgs to enable earlier detection of heart disease, today announced its financial results for the fiscal year ended april 30, 2025, and provided a business update highlighting significant strategic progress.
HSCS Ratings Summary
HSCS Quant Ranking